Skip to search formSkip to main contentSkip to account menu

lapatinib

Known as: N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine, N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine, lapatinib [Chemical/Ingredient] 
A synthetic, orally-active quinazoline with potential antineoplastic properties. Lapatinib reversibly blocks phosphorylation of the epidermal growth… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The development of the multilevel fast multipole algorithm (MLFMA) and its multiscale variants have enabled the use of integral… 
Highly Cited
2009
Highly Cited
2009
Prior studies demonstrated that resistance to the ERBB1/2 inhibitor Lapatinib in HCT116 cells was mediated by increased MCL-1… 
Highly Cited
2009
Highly Cited
2009
Abstract—Based on message passing interface (MPI) of the PC Clusters, the parallel method of moment (MOM) is applied to the… 
Highly Cited
2009
Highly Cited
2009
PURPOSE This study (EGF100262) sought to establish the recommended phase II dose of lapatinib with chemoradiotherapy in patients… 
2009
2009
In order to more exactly predict femtosecond pulse laser induced damage threshold, an accurate theoretical model taking into… 
Highly Cited
2008
Highly Cited
2008
We have defined some of the mechanisms by which the kinase inhibitor lapatinib kills HCT116 cells. Lapatinib inhibited radiation… 
2004
2004
I model journal pricing behavior in a portfolio demand environment and consider how the ongoing transition from print to digital… 
2003
2003
The results of an in-depth study of 1 nm thick individual clay sheets by atomic force microscopy (AFM) are presented. Several…